Carlos Álvarez-Fernández
- Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer
2026/07/22 by M. Galsky, Begoña P. Valderrama, Marco Maruzzo +24 · 1 voice
Medicine · #Bladder and Urothelial Cancer Treatments #Urinary and Genital Oncology Studies #Urinary Bladder and Prostate Research